Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity

Nanomedicine-Based Gene Delivery for a Truncated Tumor Suppressor RB94 Promotes Lung Cancer Immunity

Because lung cancer remains the most common and lethal of cancers, novel therapeutic approaches are urgently needed. RB94 is a truncated form of retinoblastoma tumor suppressor protein with elevated anti-tumor efficacy. Our investigational nanomedicine (termed scL-RB94) is a tumor-targeted liposomal...

Full description

Bibliographic Details
Main Authors: Sang-Soo Kim, Caroline Doherty, Manish Moghe, Antonina Rait, Kathleen F. Pirollo, Joe B. Harford, Esther H. Chang
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
non-small cell lung cancer
nanomedicine
retinoblastoma
tumor-targeted delivery
Online Access:https://www.mdpi.com/2072-6694/14/20/5092

Similar Items

Similar Items